Regentis

1 known investors

Regentis Biomaterials develops regenerative medicine products for tissue repair, focused on orthopedic cartilage and bone treatments through its Gelrin degradable hydrogel platform. Its lead product, GelrinC, is a cell-free hydrogel implant for repairing articular knee cartilage injuries, CE-marked in Europe and in US clinical trials toward PMA approval.</parameter> <parameter name="founders">[]

BiotechHealthtechMedical Devices